1-11 of 11
Gerold Bepler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non–Small Cell Lung Cancer Patients

Christine M. Lusk, Donovan Watza, Greg Dyson, Douglas Craig, Valerie Ratliff, Angela S. Wenzlaff, Fulvio Lonardo, Aliccia Bollig-Fischer, Gerold Bepler, Kristen Purrington, Shirish Gadgeel, Ann G. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (14): 4300–4308.
https://doi.org/10.1158/1078-0432.CCR-18-2439
Published: 15 July 2019
View article titled, Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non–Small Cell Lung Cancer Patients
Open the PDF for Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non–Small Cell Lung Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer

Joshua R. Heyza, Wen Lei, Donovan Watza, Hao Zhang, Wei Chen, Jessica B. Back, Ann G. Schwartz, Gerold Bepler, Steve M. Patrick
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2523–2536.
https://doi.org/10.1158/1078-0432.CCR-18-3094
Published: 15 April 2019
View article titled, Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer
Open the PDF for Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer

Erica Hlavin Bell, Arup R. Chakraborty, Xiaokui Mo, Ziyan Liu, Konstantin Shilo, Simon Kirste, Petra Stegmaier, Maureen McNulty, Niki Karachaliou, Rafael Rosell, Gerold Bepler, David P. Carbone, Arnab Chakravarti
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (10): 2396–2404.
https://doi.org/10.1158/1078-0432.CCR-15-1468
Published: 12 May 2016
View article titled, <em>SMARCA4</em>/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer
Open the PDF for <em>SMARCA4</em>/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract IA3-1: Variables for individualizing systemic therapy in patients with lung cancer

Gerold Bepler
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14_Supplement): IA3-1.
https://doi.org/10.1158/1078-0432.TCMUSA10-IA3-1
Published: 02 February 2016
View article titled, Abstract IA3-1: Variables for individualizing systemic therapy in patients with lung cancer
Journal Articles

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors

Jhanelle E. Gray, Eric Haura, Alberto Chiappori, Tawee Tanvetyanon, Charles C. Williams, Mary Pinder-Schenck, Julie A. Kish, Jenny Kreahling, Richard Lush, Anthony Neuger, Leticia Tetteh, Angela Akar, Xiuhua Zhao, Michael J. Schell, Gerold Bepler, Soner Altiok
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1644–1655.
https://doi.org/10.1158/1078-0432.CCR-13-2235
Published: 13 March 2014
View article titled, A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors
Open the PDF for A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors in another window
Journal Articles

High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma

Valsamo K. Anagnostou, Gerold Bepler, Konstantinos N. Syrigos, Lynn Tanoue, Scott Gettinger, Robert J. Homer, Daniel Boffa, Frank Detterbeck, David L. Rimm
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4157–4164.
https://doi.org/10.1158/1078-0432.CCR-09-0099
Published: 15 June 2009
View article titled, High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma
Open the PDF for High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer

Alberto A. Chiappori, Eric Haura, Francisco A. Rodriguez, David Boulware, Rachna Kapoor, Anthony M. Neuger, Richard Lush, Barbara Padilla, Michelle Burton, Charles Williams, George Simon, Scott Antonia, Daniel M. Sullivan, Gerold Bepler
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1464–1469.
https://doi.org/10.1158/1078-0432.CCR-07-1508
Published: 03 March 2008
View article titled, Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer
Open the PDF for Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer in another window
Journal Articles

Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study

George R. Simon, Christopher R. Garrett, Stephen C. Olson, Michael Langevin, Irene A. Eiseman, John J. Mahany, Charles C. Williams, Richard Lush, Adil Daud, Pamela Munster, Alberto Chiappori, Mayer Fishman, Gerold Bepler, Peter F. Lenehan, Daniel M. Sullivan
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4645–4651.
https://doi.org/10.1158/1078-0432.CCR-05-2379
Published: 09 August 2006
View article titled, Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study
Open the PDF for Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study in another window
Journal Articles

Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer

Scott J. Antonia, Noweeda Mirza, Ingo Fricke, Alberto Chiappori, Patricia Thompson, Nicholas Williams, Gerold Bepler, George Simon, William Janssen, Ji-Hyun Lee, Kerstin Menander, Sunil Chada, Dmitry I. Gabrilovich
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 878–887.
https://doi.org/10.1158/1078-0432.CCR-05-2013
Published: 07 February 2006
View article titled, Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
Open the PDF for Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer in another window
Journal Articles

Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor Survival In vivo in Non–Small Cell Lung Cancer

Eric B. Haura, Zhong Zheng, Lanxi Song, Alan Cantor, Gerold Bepler
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8288–8294.
https://doi.org/10.1158/1078-0432.CCR-05-0827
Published: 01 December 2005
View article titled, Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor Survival <em>In vivo</em> in Non–Small Cell Lung Cancer
Open the PDF for Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor Survival <em>In vivo</em> in Non–Small Cell Lung Cancer in another window
Journal Articles

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

Rafael Rosell, Kathleen D. Danenberg, Vincente Alberola, Gerold Bepler, Jose Javier Sanchez, Carlos Camps, Mariano Provencio, Dolores Isla, Miquel Taron, Pilar Diz, Angel Artal, on behalf of the Spanish Lung Cancer Group
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1318–1325.
https://doi.org/10.1158/1078-0432.CCR-03-0156
Published: 20 February 2004
View article titled, Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients
Open the PDF for Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients in another window